VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > HNY

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Dec 30, 2023 12:23am

81 Views

Post# 35804918

RE:RE:RE:HNY

MartyD wrote: First acquisitions totaled 50k shares in October 2020.

Thanks MartyD. You sounded so bubbly with your outlook I just wondered if you had been around for the consolidation ( 1 for 10) and then the collapse in 2019 when the Company came within a whisker of bankruptcy only to be bailed out by George Adams and 2 independent directors.

Things are looking considerably better these days and hopefully we will get that big news release that shows complete success. In the meantime some of us stay a little reserved. Jopat is not one of those.

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for May 2, 2024